9.86
Exagen Inc stock is traded at $9.86, with a volume of 128.87K.
It is up +1.23% in the last 24 hours and up +16.69% over the past month.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$9.74
Open:
$9.76
24h Volume:
128.87K
Relative Volume:
0.47
Market Cap:
$216.96M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-10.49
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
-2.38%
1M Performance:
+16.69%
6M Performance:
+177.75%
1Y Performance:
+229.77%
Exagen Inc Stock (XGN) Company Profile
Name
Exagen Inc
Sector
Industry
Phone
(760) 560-1501
Address
1261 LIBERTY WAY, VISTA, CA
Compare XGN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
XGN
Exagen Inc
|
9.86 | 214.32M | 52.55M | -23.69M | -15.29M | -0.94 |
![]()
TMO
Thermo Fisher Scientific Inc
|
492.72 | 184.93B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
205.82 | 147.00B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
647.09 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
125.66 | 35.50B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
190.81 | 32.08B | 15.70B | 1.24B | 2.01B | 6.91 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-30-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Jul-23-25 | Initiated | Craig Hallum | Buy |
Aug-05-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Oct-15-21 | Resumed | Cowen | Outperform |
Apr-15-21 | Initiated | Canaccord Genuity | Buy |
Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
Oct-08-20 | Initiated | BTIG Research | Buy |
Jun-02-20 | Resumed | Cantor Fitzgerald | Overweight |
Oct-14-19 | Initiated | Cantor Fitzgerald | Overweight |
Oct-14-19 | Initiated | Cowen | Outperform |
Oct-14-19 | Initiated | William Blair | Outperform |
View All
Exagen Inc Stock (XGN) Latest News
Exagen Inc. stock momentum explainedWeekly Trade Analysis & Scalable Portfolio Growth Ideas - Newser
Using R and stats models for Exagen Inc. forecastingAnalyst Upgrade & Breakout Confirmation Alerts - Newser
Is It Too Late to Sell Exagen Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
How to forecast Exagen Inc. trends using time seriesJuly 2025 Opening Moves & Reliable Price Action Trade Plans - Newser
Will Exagen Inc. price bounce be sustainableForecast Cut & AI Driven Stock Movement Reports - Newser
Exagen Inc. stock trend forecastPortfolio Performance Report & Long-Term Investment Growth Plans - Newser
Real time pattern detection on Exagen Inc. stockTrade Ideas & Verified Chart Pattern Trade Signals - Newser
Fibonacci Retracement Aligns with Support in Exagen Inc.Market Growth Summary & AI Optimized Trading Strategy Guides - beatles.ru
Risk adjusted return profile for Exagen Inc. analyzedBuy Signal & Low Risk High Reward Ideas - Newser
Volume spikes in Exagen Inc. stock – what they meanQuarterly Market Review & Free High Return Stock Watch Alerts - Newser
Is Exagen Inc. stock reversal real or fakeWeekly Risk Summary & Weekly Market Pulse Alerts - Newser
Market reaction to Exagen Inc.’s recent news2025 Biggest Moves & Safe Swing Trade Setups - Newser
How to use a screener to detect Exagen Inc. breakoutsJuly 2025 Action & AI Enhanced Trading Alerts - Newser
Smart tools for monitoring Exagen Inc.’s price actionMarket Trend Report & High Win Rate Trade Alerts - Newser
Is Exagen Inc. reversing from oversold territoryJuly 2025 WrapUp & Daily Profit Focused Stock Screening - Newser
Building trade automation scripts for Exagen Inc.Product Launch & Real-Time Stock Movement Alerts - Newser
Is There Enough Volume to Lift Exagen Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Applying chart zones and confluence areas to Exagen Inc.July 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Exagen Inc. stock daily chart insightsPortfolio Growth Summary & Long-Term Growth Stock Strategies - Newser
Is Exagen Inc. Starting a New Uptrend getLinesFromResByArray error: size == 0 - kangso.co.kr
What makes Exagen Inc. stock price move sharplyTrade Entry Report & AI Enhanced Market Trend Forecasts - Newser
Custom Dashboard Highlights Exagen Inc. Price Momentum getLinesFromResByArray error: size == 0 - newsyoung.net
Visual analytics tools that track Exagen Inc. performanceWatch List & Trade Opportunity Analysis Reports - Newser
What risks could impact Exagen Inc. stock performanceOptions Play & Expert-Curated Trade Recommendations - Newser
Exagen Inc Stock (XGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Exagen Inc Stock (XGN) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
NMSIC Co-Investment Fund, L.P. | 10% Owner |
Nov 20 '24 |
Sale |
3.30 |
200,000 |
660,040 |
2,108,958 |
Black Jeffrey G. | Chief Financial Officer |
Nov 15 '24 |
Buy |
2.98 |
22,298 |
66,448 |
274,492 |
ABALLI JOHN | President and CEO |
Nov 14 '24 |
Buy |
2.81 |
24,305 |
68,297 |
689,799 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):